Medical Record Review
Evaluation of pathology reports, imaging, laboratory tests, and previous treatments.
Pre-Travel Medical Consultation
Initial assessment of the patient's condition and treatment history.
Medical Center Coordination
Selecting the appropriate medical center based on the patient's medical records and condition.
Treatment Eligibility Assessment
Preliminary assessment of the patient's eligibility and suitability for available treatment options.
Online Medical Consultation
Coordination of an online consultation with a physician, subject to the medical center's approval.
Specialized Medical Evaluation
Review of the case by a medical team and, if necessary, a Multidisciplinary Team (MDT) cancer evaluation.
Medical Visa Application
Coordination of visa applications for the patient and one companion.
Proposed Treatment Plan
Receiving treatment options and a proposed plan from the medical center
Transfer and Transportation
Coordination of airport transfers and required medical transportation.
Accommodation and Travel Services
Arrangement of accommodation, medical interpreters, and necessary services in China.
Reference Treatment Pricing
Starting from 49,800 RMB
Post-Treatment Follow-up
Coordination of communication with the medical center and medical follow-ups after treatment.
Advanced Cancer and Cellular Therapies in China
Exotokia assists international patients in exploring specialized cancer treatment options in China, facilitating the process of medical record evaluation, coordination with medical centers, and planning their medical travel.
Each case is evaluated based on the type of cancer, disease stage, pathology results, imaging, laboratory tests, treatment history, and the patient’s current condition. The choice of treatment method and eligibility for admission depend on the evaluation of physicians and the approval of the medical center.
Treatment Options Under Review
1. Dendritic Cell (DC) Vaccine One of the cellular approaches introduced for certain projects related to
malignant tumors.2. Natural Killer (NK) Cell Therapy An immune cell-based approach proposed in certain projects related to solid tumors.
3. Activated T-Lymphocyte Therapy A cellular approach introduced for specific applications, including a project related to the prevention of liver cancer recurrence after surgery.
4. Cellular Projects for Specific Cancers Includes certain projects related to EBV-associated hematological tumors and some pancreatic and colorectal cancers.
These options are not suitable for all patients, and the feasibility of using any method must be evaluated by the medical center.
Treatment Coordination Steps
1. Obtaining patient consent and collecting
medical documents.2. Initial review of the case and completion of
required documents.3. Coordination of evaluation with the relevant medical
center.4. Receiving specialized opinions and an initial treatment proposal, if
possible.5. Receiving a cost estimate and admission-related
information.6. Coordination of travel and support services after medical center approval and the patient’s decision.
Important Notes for Patients
Diagnosis, selection of treatment method, and determination of patient eligibility are the responsibilities of the physicians and the medical center. Patient admission, treatment outcome, number of sessions, and final cost are not guaranteed.
None of the introduced methods should replace standard cancer treatment or cause delays in receiving necessary treatment without a physician’s advice.